Video

Dr Christopher M. Whaley on Receiving 2021 Seema S. Sonnad Emerging Leader in Managed Care Research Award

Conference|PCOC: Patient-Centered Oncology Care

An overview of the significance of the Seema S. Sonnad Emerging Leader in Managed Care Research Award and why the early career achievements of this year's recipient, Christopher M. Whaley, PhD, in the field of managed care deserved recognition.

Co-editors-in-chief of The American Journal of Managed Care, Michael E. Chernew, PhD, and A. Mark Fendrick, MD, discuss the significance of the Seema S. Sonnad Emerging Leader in Managed Care Research Award and why the early career achievements of this year's recipient, Christopher M. Whaley, PhD, in the field of managed care deserved recognition. Whaley and his nominator Neeraj Sood, PhD, provide added thoughts on the award.

For more on the announcement, click here.

Related Videos
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Related Content
Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com
November 21st 2024

Semaglutide Eligibility Expands to Over Half of US Adults

Cameron Santoro
Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Managed Care Cast: Frameworks for Advancing Health Equity
June 28th 2024

Frameworks for Advancing Health Equity: Trans and Gender Diverse Health Care

Giuliana Grossi
Charlie Borowicz, manager of trans and gender diverse health at Allegheny Health Network, shares how the program offers comprehensive patient-first care to those in the LGBTQ+ and gender diverse community.
Blood test | Image: Edward Jenner for Pexels
November 18th 2024

KRAKEN: Oral Muvalaplin Safely Lowers Lp(a) in Early-Stage Trial

Mary Caffrey
Results bring more competition to treat this genetically driven target for cardiovascular risk.
Managed Care Cast logo
June 18th 2024

Elevating Equitable Health Care for the LGBTQ+ Community

Maggie L. Shaw
For the third episode in our special Pride Month series, we speak with Patrick McGovern, CEO of Callen-Lorde since August of 2023 and an outspoken advocate for HIV; lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+); and community health.
Entresto packaging | Image credit: Novartis
November 18th 2024

Cardiomyopathy Risk Plummets When Sacubitril/Valsartan Taken With Chemo

Mary Caffrey
The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse events in patients less at risk of cardiomyopathy.
Kerendia press photo | Image credit: Bayer
November 18th 2024

Benefits of Finerenone Similar in Women and Men, Analysis Finds

Mary Caffrey
Follow-up results for the FINEARTS-HF trial focused on specific results for women and men, hyperkalemia risk, and an analysis of the elements of its composite end point.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo